Lucentis® Prefilled Syringe for Neovascular AMD

Ranibizumab is an anti-VEGF eye injection used for several retinal diseases. The prefilled syringe is intended for intravitreal use by trained eye specialists. This page explains what it treats, how it is given, important safety points, and how you can order and store it, including options without insurance.

What Lucentis Is and How It Works

Lucentis® prefilled syringes on Border Free Health are available with US delivery from Canada. Border Free Health connects U.S. patients with licensed Canadian partner pharmacies; prescriptions are verified with prescribers before dispensing.

This medicine contains ranibizumab, a monoclonal antibody fragment that targets VEGF-A. By binding VEGF-A, it can reduce abnormal blood vessel growth and fluid leakage in the retina. The treatment is used by ophthalmologists for conditions where VEGF-driven leakage and neovascularization harm central vision.

You can buy ranibizumab prefilled syringe through our partners once your prescriber provides a valid prescription. For condition resources, see Ophthalmology and Macular Edema.

Who It’s For

This treatment is indicated for neovascular (wet) age-related macular degeneration, diabetic macular edema, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization. It is administered only by an eye specialist familiar with intravitreal injections.

It should not be used in patients with active ocular or periocular infections, or with known hypersensitivity to ranibizumab or any component. Use is generally avoided when there is active intraocular inflammation. Discuss pregnancy and breastfeeding considerations with your prescriber.

Explore condition pages for more context: Diabetic Macular Edema and Myopic Choroidal Neovascularization.

Dosage and Usage

This injection is given into the vitreous cavity in a clinical setting using aseptic technique. Your ophthalmologist will set the schedule based on your diagnosis and response. Many patients start with monthly visits, then may move to observation periods or extended intervals if stable. The lower-dose presentation is typically used in diabetic eye disease, while other conditions often use the higher-dose presentation, per the product label.

Before each injection, clinicians check for signs of infection and measure intraocular pressure as appropriate. After the procedure, the eye is monitored for endophthalmitis and retinal complications. Do not self-inject. If you have questions about your plan, ask your healthcare professional for label-based guidance.

For broader therapy background, you can review our article on device-based injectables like Aranesp Prefilled Syringe.

Strengths and Forms

The prefilled syringe is single-use and designed for intravitreal injection by an eye specialist. Commonly available strengths include:

• 0.5 mg/0.05 mL prefilled syringe
• 0.3 mg/0.05 mL prefilled syringe

Availability may vary by market and over time. Your prescriber will select the appropriate presentation and volume per the official label. If you have questions about selection, your clinic can explain which option aligns with your condition.

Missed Dose and Timing

If a scheduled visit is missed, contact the clinic to reschedule promptly. Your prescriber may adjust the next appointment based on examination findings and imaging. Do not attempt to compensate for a missed in-clinic injection outside supervised care. Follow the plan your clinician provides.

Storage and Travel Basics

Pharmacists and clinics store this refrigerated in its original carton and protected from light. Do not freeze. If you are transporting to your prescriber for administration, keep the carton closed until the visit and avoid excessive heat. Ask the clinic how long it may remain at room temperature before use according to the label.

When traveling, use an insulated container with cool packs to help maintain appropriate conditions. Keep the carton with documentation handy for screening. Do not shake the syringe. A micro trust cue for patient confidence: temperature-controlled handling when required.

For related eye therapies that may share handling considerations, see Xalatan Ophthalmic Solution and Vyzulta Ophthalmic Solution.

Pen Handling and Sharps Disposal

This product arrives as a prefilled syringe, not a pen. Only trained clinicians should handle needle assembly and injection steps. After administration, used syringes and needles must be discarded in approved sharps containers. Do not recap needles. Follow local regulations for medical waste disposal. Patients should not attempt any part of the injection procedure at home.

Benefits

This anti-VEGF therapy can stabilize or improve vision in eligible conditions by limiting VEGF-driven leakage and neovascularization. The prefilled syringe format reduces preparation steps in clinic compared with vial withdrawal. Treatment plans can be individualized, with clinicians adjusting monitoring frequency based on response. Many patients appreciate consistent visit routines that align with imaging findings.

Side Effects and Safety

• Conjunctival redness or small surface bleeding
• Eye pain or irritation
• Floaters or visual disturbances
• Increased intraocular pressure
• Inflammation inside the eye

Serious but less common risks include endophthalmitis, retinal detachment or tear, and significant increases in intraocular pressure. Systemic arterial thromboembolic events have been reported with intravitreal anti-VEGF agents. Seek urgent care if severe pain, worsening vision, increasing redness, or light sensitivity occurs after an injection.

Drug Interactions and Cautions

Systemic exposure after ocular use is low, but combining with other anti-VEGF therapies may raise risk. Inform your healthcare professional about all medicines and supplements. Use caution in patients with recent major cardiovascular or cerebrovascular events. The treatment is not used during active ocular or periocular infections, and clinicians avoid injections when significant intraocular inflammation is present.

What to Expect Over Time

Most patients start with frequent visits while the eye is closely monitored with visual acuity tests and OCT imaging. If the retina remains dry and vision stabilizes, your prescriber may extend intervals or reduce frequency of injections according to the label and clinic protocols. Response varies. Adherence to visits helps guide the safest plan. Report any new symptoms between appointments.

Compare With Alternatives

Other approved anti-VEGF options may be considered based on your diagnosis and the clinic’s protocol. Alternatives include Eylea® and Beovu®. Your prescriber will help determine which therapy, interval strategy, and monitoring schedule fit your condition and medical history.

Pricing and Access

We make access straightforward with transparent Canadian pricing and coordination for your prescriber’s office. Check the Canada origin tag where listed. To review options and savings potential, see our relevant categories including Ophthalmology. For current Lucentis Prefilled Syringe price, add the item to your cart to view the latest figures without creating an account.

Filling through our partners supports coordination with U.S. clinics. Orders are fulfilled by licensed pharmacies and shipped securely. We provide clear documentation for clinic receipt and dispensing.

Availability and Substitutions

Stock levels can change. If a specific presentation is unavailable, a prescriber may recommend a suitable alternative or adjust the plan within label guidance. You can order Lucentis Prefilled Syringe online once your prescription is verified, and our team will work with your clinic for delivery to the appropriate address.

Patient Suitability and Cost-Saving Tips

Good candidates are patients diagnosed with the approved retinal conditions and able to attend regular ophthalmology visits. It may not be appropriate for those with active eye infections or significant intraocular inflammation. Tell your clinician about recent strokes, heart attacks, or uncontrolled pressure in the eye.

Cost-saving ideas include coordinating multi-visit plans with your clinic, bundling orders for upcoming appointments when appropriate, and setting up reminders so you do not miss refills. Discuss extended-interval strategies if your eye remains stable and your prescriber believes it is appropriate under the label. For billing clarity, ask your clinic how they manage the Lucentis Prefilled Syringe out of pocket portion versus in-office charges.

For additional eye therapies sometimes considered in care pathways, you can review Nevanac and Lumigan RC.

Questions to Ask Your Clinician

• Diagnosis details: which retinal condition is being treated?
• Visit plan: how often will monitoring occur?
• Dosing approach: fixed monthly, PRN, or treat-and-extend?
• Safety steps: how do we lower infection risk after injections?
• Vision goals: what changes should prompt an earlier visit?
• Cost planning: how will clinic and pharmacy charges be handled?

Authoritative Sources

• FDA DailyMed: Ranibizumab Injection
• Genentech: Lucentis Prescribing Information
• Health Canada Drug Product Database

Ready to proceed? You can buy Lucentis Prefilled Syringe and complete checkout with prompt, express shipping and US shipping from Canada. Prescription required. This page is informational and does not replace medical advice. Always follow the official label and your clinician’s instructions.